Medicare Enrolled
Dr. Tammy Roque, MD
Medical Oncology · Sherman, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Roque from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Roque?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Roque
Dr. Tammy Roque is a medical oncology specialist in Sherman, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Roque performed 47,208 Medicare services across 2,608 unique beneficiaries.
Between the years covered by Open Payments, Dr. Roque received a total of $3,439 from 45 pharmaceutical and/or device companies across 118 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Roque is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 21% volume in TX
$3,439 industry payments
Medicare Practice Summary
Medicare Utilization ↗47,208
Medicare services
Top 21% in TX for medical oncology
2,608
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,485 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
14,280 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 7,300 | $44 | $137 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
5,600 | $0 | $2 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
5,200 | $0 | $33 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,645 | $0 | $3 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
2,400 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 1,620 | $19 | $67 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,044 | $8 | $36 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,036 | $8 | $20 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,010 | $0 | $1 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
795 | $10 | $64 |
| Injection, granisetron hydrochloride, 100 mcg | 470 | $0 | $24 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
437 | $90 | $368 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
390 | $60 | $250 |
| Anti-nausea injection (Aloxi/palonosetron) | 270 | $1 | $114 |
| Injection, leucovorin calcium, per 50 mg | 245 | $3 | $25 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
236 | $2 | $13 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
187 | $98 | $707 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
130 | $13 | $60 |
| Iron level test | 128 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
128 | $9 | $35 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
109 | $12 | $108 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
107 | $22 | $157 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
105 | $6 | $431 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
96 | $2 | $300 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
88 | $47 | $313 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
85 | $55 | $211 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
75 | $6 | $31 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
58 | $5 | $31 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
55 | $19 | $114 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 55 | $132 | $3,675 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
54 | $11 | $96 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
49 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
49 | $6 | $34 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
49 | $49 | $344 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 43 | $90 | $657 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
40 | $21 | $161 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
39 | $1,115 | $4,802 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
38 | $47 | $686 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
35 | $7 | $29 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
34 | $1 | $7 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
31 | $59 | $821 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
29 | $4 | $26 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
29 | $15 | $94 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
29 | $41 | $143 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
29 | $1 | $8 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 28 | $20 | $128 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 28 | $339 | $1,722 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
26 | $19 | $99 |
| PSA test (prostate cancer screening) | 24 | $18 | $94 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
24 | $124 | $500 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
22 | $26 | $145 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
19 | $40 | $289 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
18 | $175 | $1,067 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
18 | $2 | $19 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
14 | $16 | $100 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
14 | $91 | $357 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
12 | $10 | $75 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
31.3% high complexity
58.8% medium
10.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,439
Total received (2018-2024)
Avg $491/year across 7 years
Bottom 48% in TX for medical oncology
45
Companies
118
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,043 (88.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$396 (11.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$822
2023
$660
2022
$319
2021
$47
2020
$528
2019
$675
2018
$388
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$273
Astellas Pharma US Inc
$251
GlaxoSmithKline, LLC.
$250
Merck Sharp & Dohme Corporation
$214
Novartis Pharmaceuticals Corporation
$196
Inari Medical, Inc.
$150
GENZYME CORPORATION
$127
AstraZeneca Pharmaceuticals LP
$125
Seagen Inc.
$124
Genentech USA, Inc.
$124
PFIZER INC.
$114
Stemline Therapeutics Inc.
$105
Celgene Corporation
$94
Pharmacyclics LLC, An AbbVie Company
$90
Daiichi Sankyo Inc.
$86
SANOFI-AVENTIS U.S. LLC
$84
Blueprint Medicines Corporation
$84
Lilly USA, LLC
$75
Exelixis Inc.
$67
Incyte Corporation
$57
EMD Serono, Inc.
$55
PharmaEssentia USA Corporation
$52
Bayer HealthCare Pharmaceuticals Inc.
$48
SOBI, INC
$45
Tempus AI, Inc
$43
ABBVIE INC.
$39
Amgen Inc.
$38
Merck Sharp & Dohme LLC
$32
Medtronic, Inc.
$32
BeiGene USA, Inc.
$31
Gilead Sciences, Inc.
$30
Agios Pharmaceuticals, Inc.
$30
ADC Therapeutics America, Inc.
$29
Rigel Pharmaceuticals, Inc.
$28
G1 Therapeutics, Inc.
$25
Janssen Biotech, Inc.
$25
Kite Pharma, Inc.
$25
AbbVie, Inc.
$25
Acrotech Biopharma LLC
$24
Aveo Pharmaceuticals, Inc.
$19
Eisai Inc.
$18
Takeda Pharmaceuticals U.S.A., Inc.
$16
EISAI INC.
$14
TerSera Therapeutics LLC
$13
Medtronic USA, Inc.
$12
Top 3 companies account for 22.5% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AYVAKIT · BELEODAQ · BESREMI · BRUKINSA · Bavencio · CALQUENCE · COSELA · Cabometyx · DOPTELET · Doptelet · ELITEK · EMPLICITI · EPKINLY · ERLEADA · Enhertu · FLOWTRIEVER CATHETER · FOTIVDA · FRUZAQLA · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · ONUREG · OPDIVO · OSTEOCOOL RF ABLATION · OSTEOCOOL RF ABLATION SYSTEM · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · Padcev · Perjeta · Pomalyst · Revlimid · Rezlidhia · S · SARCLISA · SCEMBLIX · SPRYCEL · Stivarga · TAGRISSO · TECENTRIQ · TIBSOVO · VERZENIO · Venclexta · XALKORI · XTANDI · Xofigo · Yescarta · ZEJULA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $7 per 100 Medicare services performed
Geographic Context
Medical oncologists within 10 mi
4
Per 100K population
2.9
County median income
$70,455
Nearest hospital
BAYLOR SCOTT AND WHITE SURGICAL HOSPITAL AT SHERMA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Roque is a mixed practice specialist, with above-average Medicare volume (top 21% in TX), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Roque experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Roque performed 14,280 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Roque receive payments from pharmaceutical companies?
Yes. Dr. Roque received a total of $3,439 from 45 companies across 118 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Roque's costs compare to other medical oncologists in Sherman?
Dr. Roque's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Roque) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Sherman
Browse medical oncologists in Sherman ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in TX
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in TX
Which TX medical oncologists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology